These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18064573)

  • 21. T cell abnormalities in systemic sclerosis.
    Jin W; Zheng Y; Zhu P
    Autoimmun Rev; 2022 Nov; 21(11):103185. PubMed ID: 36031049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pathogenesis of Systemic Sclerosis.
    Stern EP; Denton CP
    Rheum Dis Clin North Am; 2015 Aug; 41(3):367-82. PubMed ID: 26210124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of chemokines in the development of systemic sclerosis.
    Hasegawa M
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Feb; 31(1):23-36. PubMed ID: 18311040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells in systemic sclerosis: Advances from human and mice studies.
    Affandi AJ; Carvalheiro T; Radstake TRDJ; Marut W
    Immunol Lett; 2018 Mar; 195():18-29. PubMed ID: 29126878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The
    Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
    Front Immunol; 2018; 9():1896. PubMed ID: 30177933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of B cells in the development of systemic sclerosis.
    Yoshizaki A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
    Front Immunol; 2022; 13():938785. PubMed ID: 35967355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of scleroderma. Collagen.
    Jimenez SA; Hitraya E; Varga J
    Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological basis of systemic sclerosis.
    Zuber JP; Spertini F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of systemic scleroderma: immunological aspects].
    Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
    Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the diagnosis and treatment of systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Kowal K
    Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in animal models of systemic sclerosis.
    Asano Y
    J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathogenesis of systemic sclerosis.
    Katsumoto TR; Whitfield ML; Connolly MK
    Annu Rev Pathol; 2011; 6():509-37. PubMed ID: 21090968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of systemic sclerosis: state of the art in 2014.
    Dumoitier N; Lofek S; Mouthon L
    Presse Med; 2014 Oct; 43(10 Pt 2):e267-78. PubMed ID: 25179277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the pathogenesis of systemic sclerosis.
    Tamby MC; Chanseaud Y; Guillevin L; Mouthon L
    Autoimmun Rev; 2003 May; 2(3):152-7. PubMed ID: 12848956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.
    Distler JH; Akhmetshina A; Schett G; Distler O
    Rheumatology (Oxford); 2009 Feb; 48(2):98-103. PubMed ID: 18984611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis.
    Mo C; Zeng Z; Deng Q; Ding Y; Xiao R
    Biomed Pharmacother; 2018 Dec; 108():177-183. PubMed ID: 30219674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.